teloxantrone has been researched along with Cancer of Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, D; Ma, JC; Wang, F; Yu, J; Zhang, JX | 1 |
| Eisenhauer, E; Fine, S; Gelmon, K; Gregg, RW; Kaizer, L; Wielgosz, G | 1 |
1 trial(s) available for teloxantrone and Cancer of Lung
| Article | Year |
|---|---|
A phase II trial of DuP 937 (Teloxantrone) in non-small cell lung cancer. A study of the NCIC Clinical Trials Group.
Topics: Aged; Anthraquinones; Antineoplastic Agents; Canada; Carcinoma, Non-Small-Cell Lung; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Pyrazoles | 1993 |
1 other study(ies) available for teloxantrone and Cancer of Lung
| Article | Year |
|---|---|
The Effect of immunotherapy on oligometastatic non-small cell lung cancer patients by sites of metastasis.
Topics: Carcinoma, Non-Small-Cell Lung; Humans; Immunologic Factors; Immunotherapy; Lung Neoplasms; Retrospective Studies | 2022 |